Clinic Contributes to SCOTUS Patent Brief Re: Pharma Prices and Access to Medical Treatments
The Clinic collaborated with the R Street Institute, a nonprofit, nonpartisan, public policy research organization, on the brief. The case presents two questions relating to patent validity that will have a significant impact on pharmaceutical prices and disclosure of medical devices, and the brief argues that the Federal Circuit’s ruling — which is the subject of Medtronic’s cert petition — will exacerbate the existing problem of high medical treatment costs.
